Hepion Pharmaceuticals (HEPA) Stock Highlights

1 | -1.96%

2024-07-06 05:33:53

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Statistics

Range Today

0.96 1.07

Volume Today 12.8K

Range 1 Year

0.9 11.07

Volume 1 Year 13.01M

Range 3 Year

0.9 41

Volume 3 Year 48.83M

Range 10 Year

0.9 70336

Volume 10 Year 98.81M

Highlights

Market Capitalization 5.47M (micro)

Floating Shares 5.08M

Current Price 1

Price To Earnings -0.1

Price To Book 0.94

Earnings Per Share -9.4

Payout Ratio 0%

Performance

Latest -1.96%

1 Month -22.48%

3 Months -61.69%

6 Months -64.79%

1 Year -90.68%

3 Years -97.52%

5 Years -98.58%

10 Years -99.99%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.